Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine whether dual treatment with metformin and
alogliptin is more effective than treatment with metformin, alogliptin and pioglitazone in
the treatment of obese women with polycystic ovary syndrome (PCOS) regarding insulin
resistance and beta cell function.